Correlation Between Gain Therapeutics and Allarity Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Gain Therapeutics and Allarity Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gain Therapeutics and Allarity Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gain Therapeutics and Allarity Therapeutics, you can compare the effects of market volatilities on Gain Therapeutics and Allarity Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gain Therapeutics with a short position of Allarity Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gain Therapeutics and Allarity Therapeutics.

Diversification Opportunities for Gain Therapeutics and Allarity Therapeutics

-0.7
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Gain and Allarity is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Gain Therapeutics and Allarity Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allarity Therapeutics and Gain Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gain Therapeutics are associated (or correlated) with Allarity Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allarity Therapeutics has no effect on the direction of Gain Therapeutics i.e., Gain Therapeutics and Allarity Therapeutics go up and down completely randomly.

Pair Corralation between Gain Therapeutics and Allarity Therapeutics

Given the investment horizon of 90 days Gain Therapeutics is expected to generate 0.61 times more return on investment than Allarity Therapeutics. However, Gain Therapeutics is 1.64 times less risky than Allarity Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Allarity Therapeutics is currently generating about -0.26 per unit of risk. If you would invest  305.00  in Gain Therapeutics on September 2, 2024 and sell it today you would lose (119.00) from holding Gain Therapeutics or give up 39.02% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Gain Therapeutics  vs.  Allarity Therapeutics

 Performance 
       Timeline  
Gain Therapeutics 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Gain Therapeutics are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Gain Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Allarity Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Allarity Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's essential indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Gain Therapeutics and Allarity Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Gain Therapeutics and Allarity Therapeutics

The main advantage of trading using opposite Gain Therapeutics and Allarity Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gain Therapeutics position performs unexpectedly, Allarity Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allarity Therapeutics will offset losses from the drop in Allarity Therapeutics' long position.
The idea behind Gain Therapeutics and Allarity Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets